Study: legume-rich diet may reduce women’s diabetes risk
NEW YORK A diet rich in beans might reduce the risk of developing Type 2 diabetes by 38 percent to 47 percent, a new study published in the American Journal of Clinical Nutrition suggests.
Researchers from the Vanderbilt University Cancer Institute and the Shanghai Cancer Institute gave questionnaires to 64,227 middle-aged Chinese women who had no history of cancer, diabetes or cardiovascular disease and monitored them for about four and a half years.
Women who ate lots of legumes of any type had a 38 percent lower risk of developing Type 2 diabetes, while women with a high intake of soy beans lowered their risk by 47 percent. The risk reduction did not occur in people who ate large amounts of other soy products.
The researchers did note that the method used created the risk of reporting bias, while the results may not be universally applicable because the test only looked at Chinese women.
Westchester, N.Y., considering stricter limit on cough medicine sales
WESTCHESTER, N.Y. A new bill maybe passed in Westchester that would ban the selling of cough and cold products containing dextromethorphan to anyone under 18, according to The New York Times.
The county would follow Nassau and Suffolk who passed legislation last year banning the selling of the products to anyone under 18 and 19 respectively. Reports have shown a large increase in children taking the medications in excess to get the “high” euphoric effects that they would receive from drugs like marijuana.
If the law passes, Westchester supermarkets and drugstores that sell DXM products to minors would get a warning for the first violation and $150 fines for each subsequent offense.
Similar bans are under committee review in the United States Senate and the New York and New Jersey state legislatures. A Connecticut bill proposed in 2005 did not proceed to a vote.
Military pharmacy pulls Chantix from shelves
NEW YORK While the Federal Aviation Administration has banned pilots’ use of the anti-smoking drug Chantix, it remains available at a United States military hospital in Okinawa, Japan, the military newspaper Stars and Stripes reported in an article marked for Tuesday.
Officials at Yokota Air Base, however, have pulled it from the base’s pharmacy.
The restrictions on the drug’s use follow a report by the Institute for Safe Medication Practices linking the drug to seizures, psychosis, muscle spasms, vision disturbances and suicidal thoughts and behaviors.
The Food and Drug Administration wants the drug’s maker, Pfizer, to put new safety labels on it.
Known generically as varenicline, Chantix had sales of $883 million in 2007, according to Pfizer financial data.